Vaginitis: Diagnosis and management

International Journal of Fertility and Menopausal Studies

Volumn 41, Issue 2, 1996, Pages 115-123

  Faro, Sebastian ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

ecosystem; vaginitis; vaginosis (bacterial); vulvovaginitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CLINDAMYCIN; FLUCONAZOLE; METRONIDAZOLE; OFLOXACIN; TERCONAZOLE; TIOCONAZOLE;

BACTERIAL INFECTION; CONFERENCE PAPER; ECOSYSTEM; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; LABORATORY TEST; ORAL DRUG ADMINISTRATION; PH; PRIORITY JOURNAL; TRICHOMONIASIS; VAGINA CANDIDIASIS; VAGINITIS;

CANDIDIASIS, VULVOVAGINAL; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PROGNOSIS; TRICHOMONAS VAGINITIS; VAGINITIS; VAGINOSIS, BACTERIAL;

EID: 0029932852     PISSN: 10693130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Corson SL, Kapikian RR, Nehring R: Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison. J Repiod Med 36:561- 567, 1991.
2. Ernest JM: Topic antifungal agents. Obstet Gynecol Clin North Am 67:232-234, 1991.
3. Multicenter Study Group: Treatment of vaginal candidiasis with a single oral dose of fluconazole. Eur J Clin Microbiol Infect Dis 7:364-367, 1988.
4. Sobel JD: Pathogenesis and treatment of recurrent volvovaginal candidiasis. Clin Infect Dis 14(Suppl 1):S148-153, 1992.
5. Sobel JD, Schmitt C, Meriwether C: Clotrimazole treatment of recurrent and chronic Candida vulvovaginitis. Obstet Gynecol 73:30-34, 1989.
6. Sobel JD: Recurrent volvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. NEnglJMed 315:1455-1458, 1986.
7. Sobel JD: Individualizing treatment of vaginal candidiasis. J Am Acad Dermatol 23:572-576, 1990.
8. Munoz P, Moreno S, Berengues J, et al: Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome. Arch Intern Med 151:1020-1021, 1990.
9. Galgiani JN: Antifungal susceptibility test. Antimicrob Agents Chemother 51:1867-1870, 1987.
10. Galgiani JN: Susceptibility testing of fungi: Current status of the standardization process. Antimicrob Agents Chemother 37:2517-2521, 1993.
11. Csonka GW: Trichomonal vaginitis treated with one dose of metronidazole. Br J Vener Dis 47:456-468, 1971.
12. Edwards D, Thompson EJ, Tomusagna J, et al: Inactivation of metronidazole by aerobic organisms. J Antimicrob Chemother 5:315-316, 1979.
13. Ahmen-Jushuf IH, Murray AE, McKeown J: Managing trichomonal vaginitis refractory to conventional treatment with metronidazole. Genitourinary Med 64:25-29, 1988.
14. Muller M, Lossick JG, Gonell TE: In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex Trans Dis 15:17-24, 1988.
15. Sanford KA, Mayle JE, Dean HA, et al: Metronidazole associated pancreatitis. Ann Intern Med 109: 756-757, 1988. Goldman P: Metronidazole. N Engl f Med 303:1212-1215, 1980.
16. Andes FJ, Parker R, Hosein I, et al: Clindamycin vaginal . cream versus oral metronidazole in the treatment of bacterial vaginosis: A prospective double-blind clinical trial. South Med J 85:1077-1080, 1992.
17. Greaves WL, Chungafung S, Morris B, et al: Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 72:799-802, 1988.
18. Schmitt C, Sobel }D, Meriwether C: Bacterial vaginosis: Treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 79:1020-1023, 1992.
19. Bristoletti P, Fredricsson B, Hagstrom B, et al: Comparison of oral and vaginal metronidazole therapy for non-specific bacterial vaginosis. Gynecol Obstet Invest 21:144-149, 1986.
20. Swedberg J, Steiner JF, Deiss F, et al: Comparison of single dose vs one-week of metronidazole for symptomatic bacterial vaginosis. JAMA 254:1046-1049, 1985.
21. Hiller SL, Lipinski C, Buselden M, et al: Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstet Gynecol 81: 963-967, 1993.